| Baveno VII–renewing consensus in portal hypertension R De Franchis, J Bosch, G Garcia-Tsao, T Reiberger, C Ripoll, ... Journal of hepatology 76 (4), 959-974, 2022 | 1366 | 2022 |
| Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution M Martell, JI Esteban, J Quer, J Genesca, A Weiner, R Esteban, J Guardia, ... Journal of virology 66 (5), 3225-3229, 1992 | 1289 | 1992 |
| Hepatitis C virus antibodies among risk groups in Spain JI Esteban, L Viladomiu, A Gonzalez, M Roget, J Genesca, R Esteban, ... The Lancet 334 (8658), 294-297, 1989 | 1228 | 1989 |
| β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled … C Villanueva, A Albillos, J Genescà, JC Garcia-Pagan, JL Calleja, ... The lancet 393 (10181), 1597-1608, 2019 | 480 | 2019 |
| A MELD-based model to determine risk of mortality among patients with acute variceal bleeding E Reverter, P Tandon, S Augustin, F Turon, S Casu, R Bastiampillai, ... Gastroenterology 146 (2), 412-419. e3, 2014 | 401 | 2014 |
| Cardiac alterations in cirrhosis: reversibility after liver transplantation M Torregrosa, S Aguadé, L Dos, R Segura, A Gónzalez, A Evangelista, ... Journal of hepatology 42 (1), 68-74, 2005 | 394 | 2005 |
| High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus JI Esteban, JC López-Talavera, J Genescà, P Madoz, L Viladomiu, ... Annals of Internal Medicine 115 (6), 443-449, 1991 | 376 | 1991 |
| High prevalence of hepatitis C virus infection in diabetic patients R Simó, C Hernández, J Genescà, R Jardí, J Mesa Diabetes care 19 (9), 998-1000, 1996 | 369 | 1996 |
| Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: the “Anticipate” study JG Abraldes, C Bureau, H Stefanescu, S Augustin, M Ney, H Blasco, ... Hepatology 64 (6), 2173-2184, 2016 | 346 | 2016 |
| Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis JG Abraldes, C Villanueva, C Aracil, J Turnes, M Hernandez-Guerra, ... Gastroenterology 150 (5), 1160-1170. e3, 2016 | 321 | 2016 |
| High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry AM Moon, GJ Webb, C Aloman, MJ Armstrong, T Cargill, R Dhanasekaran, ... Journal of hepatology 73 (3), 705-708, 2020 | 310 | 2020 |
| Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease S Augustin, M Pons, JB Maurice, C Bureau, H Stefanescu, M Ney, ... Hepatology 66 (6), 1980-1988, 2017 | 290 | 2017 |
| Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study A Berzigotti, A Albillos, C Villanueva, J Genescá, A Ardevol, S Augustín, ... Hepatology 65 (4), 1293-1305, 2017 | 287 | 2017 |
| High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury A Lecube, C Hernández, J Genescà, JI Esteban, R Jardí, R Simó Diabetes care 27 (5), 1171-1175, 2004 | 277 | 2004 |
| Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: a case-control study A Lecube, C Hernández, J Genescà, R Simó Diabetes care 29 (5), 1096-1101, 2006 | 255 | 2006 |
| Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF R Moreau, J Clària, F Aguilar, F Fenaille, JJ Lozano, C Junot, B Colsch, ... Journal of hepatology 72 (4), 688-701, 2020 | 251 | 2020 |
| Antithrombotic treatment with direct‐acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis A De Gottardi, J Trebicka, C Klinger, A Plessier, S Seijo, B Terziroli, ... Liver International 37 (5), 694-699, 2017 | 239 | 2017 |
| Propranolol Plus Placebo Versus Propranolol Plus Isosorbide–5–Mononitrate in the Prevention of A First Variceal Bleed: A Double–Blind Rct JC García-Pagán, R Morillas, R Bañares, A Albillos, C Villanueva, C Vila, ... Hepatology 37 (6), 1260-1266, 2003 | 215 | 2003 |
| Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis M Simón-Talero, D Roccarina, J Martínez, K Lampichler, A Baiges, G Low, ... Gastroenterology 154 (6), 1694-1705. e4, 2018 | 207 | 2018 |
| Development of hyperdynamic circulation and response to β‐blockers in compensated cirrhosis with portal hypertension C Villanueva, A Albillos, J Genesca, JG Abraldes, JL Calleja, C Aracil, ... Hepatology 63 (1), 197-206, 2016 | 202 | 2016 |
Salvador AugustinClinical Consultant & Assistant Professor of Medicine, Vall d'Hebron Hospital, UAB, BarcelonaDirección de correo verificada de vhebron.net
